.jpg)
刘鹤媛
助理研究员
博士毕业于浙江大学，主要从事肠道营养与免疫方向研究，2020年12月入职于西安交通大学第二附属医院精准医疗研究院。
科研成果：
[1] Liu H, Huang Y, Li Z, et al. An innovative gene expression modulating strategy by converting nucleic acids into HNC therapeutics using carrier-free nanoparticles[J]. Front Immunol, 2023,14:1343428. IF=8.786
[2] Liu H, Kai L, Du H, et al. LPS Inhibits Fatty Acid Absorption in Enterocytes through TNF-alpha Secreted by Macrophages[J]. Cells, 2019,8(12). IF=7.666
[3] Liu H, Cao X, Wang H, et al. Antimicrobial peptide KR-32 alleviates Escherichia coli K88-induced fatty acid malabsorption by improving expression of fatty acid transporter protein 4 (FATP4)1[J]. J Anim Sci, 2019,97(6):2342-2356. IF=3.338
[4] Li Z, Liu H, Xu B, et al. Enterotoxigenic Escherichia coli Interferes FATP4-Dependent Long-Chain Fatty Acid Uptake of Intestinal Epithelial Enterocytes via Phosphorylation of ERK1/2-PPARgamma Pathway[J]. Front Physiol, 2019,10:798. IF=4.755
联系方式：
手机：18258204192；邮箱：hnxclhy@xjtu.edu.cn
